FDA says Turkish juice maker Yakamoz lacked a validated HACCP (juice safety) plan for lemon and lime juice.
What happened
FDA did a remote inspection of the company’s juice processing facility in Turkey from January 1 through February 2, 2022. FDA found the juice safety plan (HACCP) did not include controls to reliably reduce harmful microorganisms by the required amount, the limits set in the lemon and lime juice plan were not supported by the company’s validation studies, and revised plans lacked validation and verification procedures. FDA reviewed the company’s responses and revised HACCP plans and found them inadequate.
What FDA found
The juice safety plan lacks controls that consistently reduce the most resistant harmful microorganism by at least 5 logs for the product’s shelf life.
21 CFR 120.24(a)The critical limits for lemon and lime juice are not supported by the validation studies provided; the studies used a higher minimum acidity and different preservatives.
21 CFR Part 120The revised HACCP plans do not list validation and verification procedures such as record review, instrument calibration, and process establishment or validation studies.
21 CFR Part 120
What FDA wants
FDA asks the company to respond in writing within 15 working days from receipt of the letter with documentation of corrections, including a revised juice HACCP plan for lemon and lime juice, a validation study showing a 5-log reduction, and an updated label. If all corrections cannot be completed in 15 days, the company must explain the delay and state when it will correct the remaining violations.
Who should pay attention
- U.S. importers of lemon and lime juice
- brands that buy juice from this Turkish processor
- retailers and distributors sourcing Turkish juice
This is a summary. Read the original letter on fda.gov.